延迟发作的肌肉疼痛的物理疗法:一个框架和映射系统审查的协议与元元分析
Szczepan Wiecha1, Paweł Posadzki2,3, Robert Prill4,5
1Department of Physical Education and Health in Biala Podlaska, Faculty in Biala Podlaska, Jozef Pilsudski University of Physical Education, 00-968 Warsaw, Poland.
Journal of clinical medicine
|April 13, 2024
概括
本综合性综述综合了针对延迟发作的肌肉疼痛 (DOMS),也称为运动诱导肌肉损伤 (EIMD) 的物理治疗的证据. 它旨在澄清肌肉恢复的有效治疗方法,并为未来的研究方向提供信息.
科学领域:
- 运动医学 运动医学
- 物理疗法物理治疗
- 运动生理学 运动生理学
背景情况:
- 延迟发作的肌肉疼痛 (DOMS) 或运动诱导的肌肉损伤 (EIMD) 是由于艰苦的运动而产生的,导致疼痛和性能降低.
- 现有的对DOMS/EIMD物理治疗干预措施的系统审查提供了相互矛盾的结论,阻碍了临床决策.
- 对于管理DOMS/EIMD的最佳物理治疗护理标准缺乏共识.
研究的目的:
- 在健康成年人中系统地审查和综合对DOMS/EIMD物理治疗干预的临床结果 (有效性和安全性) 的证据.
- 评估现有证据的质量,并从相关的系统审查中绘制数据.
- 确定对DOMS/EIMD治疗有前途的疗法和潜在的研究缺口.
主要方法:
- 一个包含证据地图和元元分析的综合审查方法.
- 从1998年1月到2024年2月,搜索了多个数据库 (MEDLINE,Embase,Cochrane,Epistemonikos,PEDro) 进行随机对照试验的系统审查.
- 包括健康成年人DOMS/EIMD的物理治疗干预 (例如激光治疗,电刺激,热/冷,超声波,按摩);不包括叙事评论和非物理治疗干预.
主要成果:
- 该审查批判性地评估了对DOMS/EIMD物理治疗现有的系统性审查的质量和重叠.
- 将生成一个证据地图,以视觉地表示各种干预措施的证据可信度.
- 包括系统审查中的数据将被总结,以确定趋势和不一致性.
结论:
- DOMS/EIMD是一种复杂的疾病,没有普遍同意的护理标准.
- 这一综合性审查将为临床医生提供对DOMS/EIMD潜在有效疗法的见解.
- 预计这些发现将通过突出当前证据库中的差距来指导未来的研究.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Muscle Recovery and Fatigue
2.1K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.1K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.3K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.3K
Skeletal Muscle Relaxants: Adverse Effects
363
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
363
Centrally Acting Muscle Relaxants: Therapeutic Uses
675
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
675


